Go to the article
- People
- Offices
- Capabilities
back- Capabilities
- Corporate, Finance and Investments
- back
- Corporate, Finance and Investments
- Overview
- Activist Defense
- Capital Markets
- Construction and Procurement
- Corporate Governance
- Emerging Companies and Venture Capital
- Employee Benefits and Executive Compensation
- Energy and Infrastructure Projects
- Financial Restructuring
- Fund Finance
- Global Human Capital and Compliance
- Investment Funds and Asset Management
- Leveraged Finance
- Mergers and Acquisitions (M&A)
- Middle East and Islamic Finance and Investment
- Private Equity
- Public Companies
- Real Estate
- Structured Finance and Securitization
- Tax
- Technology Transactions
- Government Matters
- back
- Government Matters
- Overview
- Antitrust
- Data, Privacy and Security
- Environmental, Health and Safety
- FDA and Life Sciences
- Government Advocacy and Public Policy
- Government Contracts
- Healthcare
- Innovation Protection
- International Trade
- National Security and Corporate Espionage
- Securities Enforcement and Regulation
- Special Matters and Government Investigations
- Trial and Global Disputes
- back
- Trial and Global Disputes
- Overview
- Antitrust
- Appellate, Constitutional and Administrative Law
- Bankruptcy and Insolvency Litigation
- Class Action Defense
- Commercial Litigation
- Corporate and Securities Litigation
- E-Discovery
- Global Construction and Infrastructure Disputes
- Innovation Protection
- Intellectual Property
- International Arbitration and Litigation
- Labor and Employment
- Product Liability
- Professional Liability
- Toxic & Environmental Torts
- Industries / Issues
- back
- Industries / Issues
- Automotive, Transportation and Mobility
- Energy Transition
- Energy
- Financial Services
- Food and Beverage
- Higher Education
- Life Sciences and Healthcare
- Technology
- Artificial Intelligence (AI) and Machine Learning
- Buy American
- Crisis Management
- Doing Business in Latin America
- Environmental Agenda
- Environmental, Social and Governance (ESG)
- Focus on Women's Health
- Russia/Ukraine
- Special Purpose Acquisition Companies (SPACs)
- Careers
- News & Insights
- About
- Languages
News & Insights
In the News
July 1, 2026 - Source: Law360
Ashley Parrish, Paul Alessio Mezzina, Nikki Reeves, Alexander Kazam, Nicholas Mecsas-Faxon, Cliff Stricklin and Jared Lax obtain a favorable ruling on behalf of Amgen in a dispute with the state of Colorado over its price cap for the arthritis drug Enbrel
Featured Lawyers
Ashley C. Parrish
Washington, D.C.
Paul Alessio Mezzina
Washington, D.C.
Nikki Reeves
Washington, D.C.
Nicholas Andrew Mecsas-Faxon (Nick)
Washington, D.C.
Cliff Stricklin
Denver
Jared Lax
Denver
Close
Featured Lawyers
Ashley C. Parrish
Washington, D.C.
Paul Alessio Mezzina
Washington, D.C.
Nikki Reeves
Washington, D.C.
Nicholas Andrew Mecsas-Faxon (Nick)
Washington, D.C.
Cliff Stricklin
Denver
Jared Lax
Denver